eMERGE is a national network organized and funded by the National Human Genome Research Institute (NHGRI) that combines DNA biorepositories with electronic medical record (EMR) systems for large scale, high-throughput genetic research in support of implementing genomic medicine.
Many factors contribute to risk of a disease. Some of these factors are internal, like genetics, and others are external, like where someone lives. Over the last several years researchers have discovered that in addition to one gene being associated with a given disease (monogenic factors), many genes across your genome can contribute to the development of a disease (polygenic factors). To learn more about elements that contribute to risk a disease, click here.
NHGRI Research Training & Career Development Annual Meeting
November 11, 2022 7:50 PM
Nature Scientific Reports proposed a special issue entitled Pharmacogenomics for Precision Medicin
October 10, 2022 3:56 PM
NIH Funding Opportunities for Community Organization Partnerships: LOI due Nov. 19. TA Webinar available on Demand
October 10, 2022 3:15 PM
AnVIL Clinical Resource (ACR) Funding Opportunity Announcement
September 9, 2022 5:08 PM
NHGRI published three companion RFAs for the Multi-Omics for Health and Disease Consortium
September 9, 2022 8:21 PM
INVITATION TO PARTICIPATE IN THE NIH OITE BECOMING A RESILIENT SCIENTIST SERIES
August 8, 2022 6:21 PM
Chung CP, Karakoc G, Liu G, Gamboa JL, Kawai V. Ancestry, ACKR1 and leucopenia in patients with systemic lupus erythematosus. Lupus science & medicine. 2022 Nov;9(1).
Obeng AO, Scott SA, Kaszemacher T, Ellis SB, Bottinger EP, et al. Prescriber Adoption of SLCO1B1 Genotype-Guided Simvastatin Clinical Decision Support in a Clinical Pharmacogenetics Program. Clinical pharmacology and therapeutics. 2022 Nov 13;.
Robinson JR, Carroll RJ, Bastarache L, Chen Q, Denny JC, et al. Quantifying the phenome-wide disease burden of obesity using electronic health records and genomics. Obesity (Silver Spring, Md.). 2022 Dec;30(12):2477-2488.